Status:

COMPLETED

Tonometry Precision and Accuracy During PROSE Scleral Lens Wear: A Pilot Study

Lead Sponsor:

Boston Sight

Conditions:

Intraocular Pressure and PROSE Lens

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this research is to determine the reproducibility of measurements of intraocular pressure (IOP) when a scleral lens is on the eye. The PROSE device (PD) is a specialized scleral lens that ...

Detailed Description

The goal of this research is to determine the reproducibility of measurements of intraocular pressure (IOP) when a scleral lens is on the eye. This is a prospective study of the reproducibility of th...

Eligibility Criteria

Inclusion

  • Written Informed Consent has been obtained prior to any study-related procedures taking place
  • Written documentation has been obtained in accordance with the relevant county and local privacy requirements, where applicable
  • Male or female, 18 years of age and older prior to the initial visit
  • Is an established wearer of PROSE in both eyes; without fenestrations or channels; with diameter equal to or greater than 18.0 mm
  • Upon examination by the investigator, there is adequate exposure of the sclera as required for IOP measurements with the planned device
  • In the opinion of the investigator, the subject has the ability to follow study instructions
  • In the opinion of the investigator, the subject has the ability to complete all study procedures and visits

Exclusion

  • Is aphakic (i.e., missing their natural lens inside the eye)
  • Is currently participating in any other type of eye-related clinical or research study
  • Is pregnant or nursing as reported by the subject
  • Less than 18 years of age
  • Has a condition or is in a situation which, in the investigator's opinion, may put the subject at significant risk, may confound study outcomes, or may significantly interfere with the subject's participation in the study
  • Has had previous ocular surgery within the past 12 weeks
  • Has a diagnosis of glaucoma, glaucoma suspect, ocular hypertension or prior glaucoma surgery

Key Trial Info

Start Date :

April 13 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 27 2021

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04308941

Start Date

April 13 2020

End Date

April 27 2021

Last Update

November 9 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

BostonSight

Needham, Massachusetts, United States, 02494